Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: Associations with prednisone, disease-modifying antirheumatic drugs, and anti–tumor necrosis factor therapy-Reference-Cited by-同舟云学术

Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: Associations with prednisone, disease-modifying antirheumatic drugs, and anti–tumor necrosis factor therapy

Published:2006 Issue:2 Volume:54 Page:628-634
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Wolfe Frederick,Caplan Liron,Michaud Kaleb

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference56 articles.

1. The mortality of rheumatoid arthritis

2. . The lung in rheumatic diseases. In: , , , , editors. Rheumatology. New York: Mosby; 2003. p. 315–25.

3. Gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease.

4. EUROPEAN LEAGUE AGAINST RHEUMATISM STUDY OF ADVERSE REACTIONS TO D-PENICILLAMINE

Cited by 383 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of pneumococcal vaccination in adults with common immune-mediated inflammatory diseases in the UK: a case–control study;The Lancet Rheumatology;2024-09

2. Application of Injectable Hydrogels as Delivery Systems in Osteoarthritis and Rheumatoid Arthritis;British Journal of Hospital Medicine;2024-08-30

3. Incidence of serious infections in the working‐age Japanese adult population with rheumatoid arthritis treated with tumor necrosis factor‐α inhibitors and interleukin‐6 inhibitors: A nationwide retrospective cohort study;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-06-12

4. Ultrasound-actuated drug delivery with acoustic percolation switches;2024-05-14

5. Risk factor of non-tuberculous Mycobacterium infection in patients with rheumatoid arthritis and other autoimmune diseases receiving biologic agents: A multicenter retrospective study;Respiratory Investigation;2024-05